Stimcell Energetics (STME) Profit After Tax Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 12.74% |
| Nov 30, 2025 | -10.35% |
| Aug 31, 2025 | -5.71% |
| May 31, 2025 | 2.73% |
| Feb 28, 2025 | 11.50% |
| Nov 30, 2024 | 14.40% |
| Aug 31, 2024 | 22.88% |
| May 31, 2024 | 36.42% |
| Feb 29, 2024 | 18.20% |
| Nov 30, 2023 | 13.84% |
| Aug 31, 2023 | 20.57% |
| May 31, 2023 | 19.60% |
| Feb 28, 2023 | 16.77% |
| Nov 30, 2022 | 4.67% |
| Aug 31, 2022 | 28.59% |
| May 31, 2022 | -19.26% |
| Feb 28, 2022 | 17.07% |
| Nov 30, 2021 | 30.17% |
| Aug 31, 2021 | 3.01% |
| May 31, 2021 | 10.90% |
| Feb 28, 2021 | 9.57% |
| May 31, 2018 | -175.09% |
| Feb 28, 2018 | -115.73% |
| Nov 30, 2017 | -106.72% |
| May 31, 2017 | 180.57% |
| Feb 28, 2017 | -136.59% |
| Nov 30, 2016 | -182.59% |
| Aug 31, 2016 | -139.01% |
| May 31, 2016 | -201.77% |